INTRODUCTION

CONCLUSIONS
■■ ■
Most patients seek help relatively quickly but some delay; this indicates that education about the importance of early diagnosis is needed.
Most patients and caregivers believe that there are a number of obstacles in managing wAMD, including finding the right treatment options.
■■ ■ wAMD has a major impact on the lives of patients and caregivers, and may be associated with an economic burden (eg, lost productivity).
There is a need to investigate further what factors are driving patient compliance.
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FIGURE 1:
There is consistency between symptoms reported by patients (n=910) and caregivers (n=890). 
Treatment and Follow-up
■ ■ 54% of patients started treatment immediately, and 37% scheduled an appointment within 1-3 weeks.
■ ■ 42% of patients attended appointments once every 4-6 weeks, and 59% of these received treatment at every visit (compared with 18% for those attending every 6-12 months).
■ ■ 52% of patients reported a temporary improvement or stabilisation in vision as a result of current treatment, and 22% reported a return to pre-diagnosis vision or that their vision was still improving.
■ ■ Since treatment initiation, 30% of caregivers were able to reduce the level of care. 
Obstacles to Treatment
Burden of Disease
■ ■ 72% of patients reported that wAMD had a negative impact. Most reported an effect on practical day-today activities; this impact was perceived as greater by caregivers (Figure 3 ). ■ ■ 26% of patients had also experienced a fall, with 34% of these having been hospitalised as a result.
■ ■ wAMD was also associated with a range of emotional effects; the biggest fear (60%) was permanent loss of vision.
Loss of Productivity
■ ■ 27% of caregivers found the patient's treatment extremely inconvenient, with 57% of employed (non-paid) caregivers having to take time off work or miss personal obligations as a result of helping the patient (Figure 4 ). ■ ■ 16% of patients missed an HCP appointment because their caregiver was unable to take them (26%), because of fear of injections (21%), illness (19%), forgetfulness (15%), inconvenience (10%), costs (6%), and discomfort of injections (3%).
